On January 3, 2017, the Institutional Review Board (IRB) at Emory University approved the first protocol amendment for our upcoming Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. Principal Investigator Barbara Rothbaum, Ph.D., a leading PTSD researcher, will conduct the study at Emory University in Atlanta, Georgia. The required safe for the study drug is installed, and we are ready for inspection by the Drug Enforcement Administration (DEA). The study will begin after DEA approval. Learn more…
